Oruka Therapeutics, Inc. (HQ1)
Market Closed
17 Jul, 20:00
XSTU 
€
71. 50
-1
-1.3793%
€
- Market Cap
- P/E Ratio
6.45% Div Yield
200 Volume
- Eps
€ 72.5
Previous Close Want to track HQ1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oruka Therapeutics, Inc. (HQ1) Statistics
Valuation metrics
Market Cap -
Enterprise value -45M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.43
Overview
Shares outstanding 48.72M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 43
Average volume (90 days) 88
Price summary
52-Week low 11
52-Week high 85
Beta -
50-Day moving average 47.89
200-Day moving average 28.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 28 Aug 2024
Ex-Dividend Date 29 Aug 2024
Last split factor 1:12
Last split Date 3 Sep 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.22%
Return on equity -0.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -105.43M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 1.93M
Total Debt/Equity (mrq) 0
Current ratio (mrq) 22.37%
Book value per share (mrq) -
Cash Flow
Cash flow statement -91.48M
Levered free cash flow (LFCF) -105.43M
